These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. Shorr AF. IRB; 1992; 14(4):1-5. PubMed ID: 11651391 [No Abstract] [Full Text] [Related]
4. An overview of legal controls on human experimentation and the regulatory implications of taking Professor Katz seriously. Goldner JA. St Louis Univ Law J; 1993; 38(1):63-134. PubMed ID: 11656325 [No Abstract] [Full Text] [Related]
9. Building a new consensus: ethical principles and policies for clinical research on HIV/AIDS. Levine C, Dubler NN, Levine RJ. IRB; 1991; 13(1-2):1-17. PubMed ID: 11659323 [No Abstract] [Full Text] [Related]
11. A relational perspective on ethics-in-science decisionmaking for research with vulnerable populations. Fisher CB. IRB; 1997; 19(5):1-4. PubMed ID: 11655184 [No Abstract] [Full Text] [Related]
12. Minors' assent, consent, or dissent to medical research. Leikin S. IRB; 1993; 15(2):1-7. PubMed ID: 11651566 [No Abstract] [Full Text] [Related]
13. The paradoxical case of payment as benefit to research subjects. Macklin R. IRB; 1989; 11(6):1-3. PubMed ID: 11650284 [No Abstract] [Full Text] [Related]
14. Decisional capacity, older human research subjects, and IRBs: beyond forms and guidelines. Kapp MB. Stanford Law Pol Rev; 1998; 9(2):359-71. PubMed ID: 11657514 [No Abstract] [Full Text] [Related]
16. Legal aspects of experimentation with institutionalized mentally disabled subjects. Laves BS. J Clin Pharmacol New Drugs; 1998; 16(10):. PubMed ID: 11664683 [No Abstract] [Full Text] [Related]
17. Balancing moral principles in federal regulations on human research. Ackerman TF. IRB; 1992; 14(1):1-6. PubMed ID: 11652041 [No Abstract] [Full Text] [Related]